# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Keybanc analyst Brett Fishbin maintains Alcon (NYSE:ALC) with a Overweight and lowers the price target from $98 to $91.
Shareholders Have the Information They Need to Make an Informed VotePreliminary Net Sales Results for Third Quarter Underscore ...
Leading Proxy Advisory Firms ISS, Glass Lewis, and Egan-Jones, as well as Long-Term Shareholders Echo Broadwood's Concerns ...
Barclays analyst Matt Miksic initiates coverage on Alcon (NYSE:ALC) with a Equal-Weight rating and announces Price Target of...
BTIG analyst Ryan Zimmerman maintains Alcon (NYSE:ALC) with a Buy and lowers the price target from $92 to $91.
Raises Concerns About Whether the Board Fulfilled Its Fiduciary Duty of Care in Doubling Down on Its Commitment to Proposed Tra...
Defender Capital ("Defender" or "we"), a long-term shareholder of STAAR Surgical Company ("STAAR" or th...